Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway

Kidney Int. 2008 Sep;74(5):577-84. doi: 10.1038/ki.2008.210. Epub 2008 May 28.

Abstract

Statins are known to lessen the severity of renal ischemia-reperfusion injury. The present study was undertaken to define the mechanism of renoprotective actions of statins using a mouse kidney injury model. Treatment of mice with pravastatin, a widely used statin, improved renal function after renal ischemia-reperfusion without lowering the plasma cholesterol level. Administration of pravastatin with mevalonate, a product of HMG-CoA reductase, eliminated renal protection suggesting an effect of pravastatin on mevalonate or its metabolism. In hypercholestrolemic apolipoprotein E knockout mice with reduced HMG-CoA reductase activity; the degree of injury was less severe than in control mice, however, there was no protective action of pravastatin on renal injury in the knockout mice. Treatment with a farnesyltransferase inhibitor (L-744832) mimicked pravastatin's protective effect but co-administration with the statin provided no additional protection. Both pravastatin and L-744832 inhibited the injury-induced increase in plasma IL-6 concentration to a similar extent. Our results suggest the protective effect of pravastatin on renal ischemia-reperfusion injury is mediated by inhibition of the mevalonate-isoprenoid pathway independent of its lipid lowering action.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / drug therapy
  • Acute Kidney Injury / etiology
  • Acute Kidney Injury / physiopathology
  • Animals
  • Apolipoproteins E / deficiency
  • Apolipoproteins E / genetics
  • Cholesterol / blood
  • Creatinine / blood
  • Enzyme Inhibitors / administration & dosage
  • Farnesyltranstransferase / antagonists & inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
  • Hyperlipidemias / complications
  • Hyperlipidemias / drug therapy
  • Kidney / blood supply*
  • Kidney / drug effects
  • Kidney / injuries*
  • Kidney / physiopathology
  • Male
  • Methionine / administration & dosage
  • Methionine / analogs & derivatives
  • Mevalonic Acid / administration & dosage
  • Mevalonic Acid / antagonists & inhibitors*
  • Mevalonic Acid / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Pravastatin / administration & dosage
  • Pravastatin / pharmacology*
  • Reperfusion Injury / drug therapy*
  • Reperfusion Injury / pathology
  • Reperfusion Injury / physiopathology
  • Reperfusion Injury / prevention & control
  • Terpenes / metabolism

Substances

  • Apolipoproteins E
  • Enzyme Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • L 744832
  • Terpenes
  • Cholesterol
  • Methionine
  • Creatinine
  • Farnesyltranstransferase
  • Pravastatin
  • Mevalonic Acid